[go: up one dir, main page]

IL165129A0 - Treatment of post-menopausal complaints in breast cancer pateins comprising tibolone and a serm - Google Patents

Treatment of post-menopausal complaints in breast cancer pateins comprising tibolone and a serm

Info

Publication number
IL165129A0
IL165129A0 IL16512904A IL16512904A IL165129A0 IL 165129 A0 IL165129 A0 IL 165129A0 IL 16512904 A IL16512904 A IL 16512904A IL 16512904 A IL16512904 A IL 16512904A IL 165129 A0 IL165129 A0 IL 165129A0
Authority
IL
Israel
Prior art keywords
pateins
tibolone
serm
post
treatment
Prior art date
Application number
IL16512904A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL165129A0 publication Critical patent/IL165129A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL16512904A 2002-05-24 2004-11-09 Treatment of post-menopausal complaints in breast cancer pateins comprising tibolone and a serm IL165129A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077050 2002-05-24
PCT/EP2003/050178 WO2003099292A1 (en) 2002-05-24 2003-05-20 Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm

Publications (1)

Publication Number Publication Date
IL165129A0 true IL165129A0 (en) 2005-12-18

Family

ID=29558370

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16512904A IL165129A0 (en) 2002-05-24 2004-11-09 Treatment of post-menopausal complaints in breast cancer pateins comprising tibolone and a serm

Country Status (14)

Country Link
US (1) US20050222100A1 (es)
EP (1) EP1511497A1 (es)
JP (1) JP2005531575A (es)
KR (1) KR20050005490A (es)
CN (1) CN1655796A (es)
AR (1) AR039843A1 (es)
AU (1) AU2003273170A1 (es)
BR (1) BR0311146A (es)
CA (1) CA2487268A1 (es)
IL (1) IL165129A0 (es)
MX (1) MXPA04011687A (es)
PE (1) PE20031047A1 (es)
TW (1) TW200307553A (es)
WO (1) WO2003099292A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2234060A1 (en) * 1995-10-06 1997-04-10 Arch Development Corporation Methods and compositions for viral enhancement of cell killing
WO2007143607A2 (en) 2006-06-02 2007-12-13 Pear Tree Women's Health Care Method of treating atrophic vaginitis
US8933130B2 (en) 2006-06-23 2015-01-13 Radius Health, Inc. Treatment of vasomotor symptoms with selective estrogen receptor modulators
US20110124617A1 (en) * 2008-05-09 2011-05-26 Lyttle C Richard Combination Therapy for BreastCancer Comprising an Antiestrogenic Agent
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
MX342898B (es) 2010-05-12 2016-10-18 Radius Health Inc * Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol.
ES2550319T3 (es) 2010-09-28 2015-11-06 Radius Health, Inc Moduladores selectivos del receptor de andrógenos
SI3122426T1 (sl) 2014-03-28 2023-04-28 Duke University Zdravljenje raka dojk z uporabo selektivnih modulatorjev estrogenskih receptorjev
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
IL255189B2 (en) 2015-04-29 2024-04-01 Radius Pharmaceuticals Inc A combination of rad1901 and a cdk4/6 inhibitor for use in treating cancer
CA3027563C (en) 2016-06-22 2024-07-02 Ellipses Pharma Ltd AR+ METHODS FOR BREAST CANCER TREATMENT
ES2981967T3 (es) 2017-01-05 2024-10-14 Radius Pharmaceuticals Inc Formas polimórficas de RAD1901-2HCl
WO2020010216A1 (en) 2018-07-04 2020-01-09 Radius Pharmaceuticals, Inc. Polymorphic forms of rad 1901-2hcl
PH12021551950A1 (en) 2019-02-12 2022-05-23 Radius Pharmaceuticals Inc Processes and compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK9592002A3 (en) * 2000-01-28 2003-12-02 Endorech Inc A method for reduction or elimination of the incidence of menopausal symptoms, method of treatment or decreasing the risk of an acquiring disease, a pharmaceutical composition and a kit
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
WO2003011282A1 (en) * 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins

Also Published As

Publication number Publication date
KR20050005490A (ko) 2005-01-13
CN1655796A (zh) 2005-08-17
AU2003273170A1 (en) 2003-12-12
WO2003099292A1 (en) 2003-12-04
TW200307553A (en) 2003-12-16
EP1511497A1 (en) 2005-03-09
PE20031047A1 (es) 2003-12-23
US20050222100A1 (en) 2005-10-06
AR039843A1 (es) 2005-03-02
JP2005531575A (ja) 2005-10-20
CA2487268A1 (en) 2003-12-04
MXPA04011687A (es) 2005-03-31
BR0311146A (pt) 2005-03-15

Similar Documents

Publication Publication Date Title
IL165129A0 (en) Treatment of post-menopausal complaints in breast cancer pateins comprising tibolone and a serm
IL166076A0 (en) Pramipexole once-daily dosage form
IL166079A0 (en) Sustained-release tablet comprising reboxetine
IL163734A (en) Shaped tampon
EP1482970A4 (en) ANTICANCER THERAPY
AU2003235618A8 (en) Ultrasonic treatment of breast cancer
GB0212885D0 (en) Therapeutic epitopes and uses thereof
IL164211A0 (en) Il-18 inhibitors and peripheral vascular diseases
AU2003236211A8 (en) Smac-peptides as therapeutics against cancer and autoimmune diseases
GB0212405D0 (en) Composition and its therapeutic use
GB0005257D0 (en) Breast cancer hormonal therapy
GB0207410D0 (en) Compounds and their therapeutic use
AU2003293130A8 (en) Methods for identifying risk of breast cancer and treatments thereof
IL165725A0 (en) Immunotoxin as a therapeutic agent and uses thereof
EP1569928A4 (en) THERAPEUTIC COMPOUNDS AND METHOD
AU2003231803A8 (en) Treatment of cancer with mefloquire
AU2002360815A8 (en) Human breast cancer biomarkers
GB0226595D0 (en) Cancer therapy determination
EP1583543A4 (en) METHOD AND THERAPEUTIC COMPOSITIONS IN THE TREATMENT OF ADVANCED CARCINOMA
GB2394659B (en) Therapeutic and prophylactic preparations
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
AU2003298742A8 (en) Methods for identifying risk of breast cancer and treatments thereof
GB2383538B (en) Cancer treatment
SI1427420T1 (sl) Uporaba kombinacije, ki vsebuje 4-piridilmetilftalazine za zdravljenje raka
GB0205826D0 (en) Therapeutic compositions and methods